NCT07629453

Brief Summary

Chronic post-surgical pain (CPSP) represents a major clinical problem associated with impaired functional recovery, reduced quality of life, prolonged opioid use, and increased healthcare utilization. The mechanisms underlying pain chronification are multifactorial and involve complex interactions among surgical trauma, inflammatory responses, central sensitization, neuroimmune activation, and psychosocial risk factors. The CROPS study (Chronification of Post-Surgical Pain and Risk Assessment) is a prospective multicenter randomized controlled trial designed to evaluate the impact of perioperative analgesic strategies on the development of chronic post-surgical pain and to validate a novel questionnaire-based pain chronification risk assessment tool in adult patients undergoing cardiac surgery. Participants will be randomized to receive either standard multimodal opioid-based perioperative analgesia or regional anesthesia-based perioperative analgesia incorporating chest wall plane block techniques, including erector spinae plane block, paravertebral block, or PECS block, according to institutional practice. The study will compare postoperative pain intensity, opioid consumption, postoperative recovery, postoperative complications, health-related quality of life, and the incidence of chronic post-surgical pain at 3 months after surgery. In parallel, the predictive performance of the pain chronification risk assessment questionnaire will be evaluated using discrimination and calibration analyses. The study is conducted as an investigator-initiated academic collaboration between the East Slovakia Institute of Cardiovascular Diseases, Košice, Slovakia, and Uppsala University Hospital, Uppsala, Sweden.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
33mo left

Started Sep 2026

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2026

Completed
19 days until next milestone

First Posted

Study publicly available on registry

June 5, 2026

Completed
3 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2028

6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2029

Last Updated

June 5, 2026

Status Verified

June 1, 2026

Enrollment Period

2.3 years

First QC Date

May 17, 2026

Last Update Submit

June 4, 2026

Conditions

Keywords

chronic post-surgical paincardiac surgeryregional anesthesiapostoperative analgesia

Outcome Measures

Primary Outcomes (1)

  • Incidence of Chronic Post-Surgical Pain at 3 Months

    Presence of chronic post-surgical pain assessed 3 months after surgery using the Brief Pain Inventory questionnaire and pain intensity evaluation.

    3 months after surgery

Secondary Outcomes (12)

  • Postoperative Pain Intensity

    Postoperative days 1-7

  • Perioperative Opioid Consumption

    Postoperative days 1-7

  • Brief Pain Inventory Score Changes

    Baseline, 1 week, and 3 months after surgery

  • Validation of Pain Chronification Risk Assessment Questionnaire

    Baseline assessment with 3-month follow-up

  • Quality of Life Assessment

    Baseline and 3 months after surgery

  • +7 more secondary outcomes

Study Arms (2)

Standard Multimodal Opioid-Based Analgesia

ACTIVE COMPARATOR

Participants will receive standard multimodal opioid-based perioperative analgesia according to institutional cardiac surgery pain management protocols.

Procedure: Standard Multimodal Opioid-Based Analgesia

Regional Anesthesia-Based Analgesia

EXPERIMENTAL

Participants will receive regional anesthesia-based perioperative analgesia including chest wall plane block techniques in combination with multimodal analgesia during cardiac surgery.

Procedure: Regional Anesthesia-Based Analgesia

Interventions

Standard perioperative pain management including opioid-based multimodal analgesia administered according to institutional cardiac surgery protocols.

Standard Multimodal Opioid-Based Analgesia

Regional anesthesia-based perioperative analgesia including chest wall plane block techniques such as erector spinae plane block, PECS block, or paravertebral block in combination with multimodal analgesia during cardiac surgery.

Regional Anesthesia-Based Analgesia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥18 years
  • Elective cardiac surgery requiring median sternotomy, including:
  • coronary artery bypass grafting (CABG)
  • aortic valve replacement or repair
  • mitral valve replacement or repair
  • ascending aorta surgery
  • Ability to understand study information
  • Ability to provide written informed consent
  • Expected postoperative hospital stay longer than 3 days
  • Availability for follow-up at 1 week and 3 months after surgery

You may not qualify if:

  • Emergency surgery
  • Cognitive impairment preventing study participation
  • Serious psychiatric illness interfering with study participation
  • Language barrier preventing questionnaire completion
  • Participation in another interventional study affecting pain outcomes
  • Reoperation for postoperative bleeding
  • Severe chronic renal failure
  • Allergy or contraindication to study medication or regional anesthesia techniques
  • Pregnancy or breastfeeding
  • Chronic opioid therapy exceeding 60 mg morphine equivalents daily
  • Extensive emergency aortic surgery (e.g., Thoraflex implantation for acute aortic dissection)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Martuliak I, Golubnitschaja O, Chvala L, Kapalla M, Ferencik M, Bubeliny M, Venglarcik M, Kocan L. Pain chronification risk assessment: advanced phenotyping and scoring for prediction and treatments tailored to individualized patient profile. EPMA J. 2024 Nov 15;15(4):739-750. doi: 10.1007/s13167-024-00383-3. eCollection 2024 Dec.

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Peter Kostic, MD, PhD

    Department of Heart and Lung Diseases, Unit for Cardiothoracic Surgery, Anesthesia and Intensive Care, Uppsala University Hospital, 751 85 Uppsala, Sweden

    STUDY CHAIR

Central Study Contacts

Ladislav Kočan, assoc. prof, MD, PhD

CONTACT

Peter Kostič, MD PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of regional anesthesia interventions, masking of participants and care providers is not feasible.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants undergoing elective cardiac surgery will be randomized in a parallel assignment design to receive either conventional multimodal opioid-based perioperative analgesia or regional anesthesia-based chest wall plane block techniques as part of perioperative pain management.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator and Study Chair

Study Record Dates

First Submitted

May 17, 2026

First Posted

June 5, 2026

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

December 1, 2028

Study Completion (Estimated)

June 1, 2029

Last Updated

June 5, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Individual participant data sharing has not yet been determined. Data sharing policies will be evaluated after study completion in accordance with institutional regulations, ethical approvals, and patient privacy requirements.